"OVID helped us develop our patient engagement strategy and I found working with the team on this really refreshing. They’re well organised and listened carefully to our challenges before creating a plan. I was impressed with the efficiency of their execution, particularly how they gathered insights across the organisation. I’m really pleased with what we have now, which is a very clear, solid and workable strategy. Thank you."

Ian Stiles
Director of Rare Blood Disorders/ Novo Nordisk

OVID have been an excellent PR partner for us as a start-up, bringing both much-needed skills and experience to the team, as well as challenge and rigour to our thinking. Their expertise and insight into both the global pharmaceutical market and the UK policy arena have been really valuable, and the quality of their writing is excellent. Contracting and delivery were tightly managed, and they delivered over and above on our original KPIs

Piers Kotting
CEO / RareCan

I was impressed by how quickly OVID got to know our business and how they helped us define our narrative as a company. Their strategic advice on messaging, the design of our IR slides, and our website was spot on, exactly what we needed to make an impression on potential investors and customers.

Dr Lorin Gresser
CEO / DemDX

“OVID Health is an agency with exciting ideas and is not afraid to lead from the front, and with the Cell & Gene Collective, they have done just that. OVID brought together industry leaders and developed a strategy that brought a new impetus to the cell and gene therapy landscape with a strong patient centric ethos.”

Anita Ralli
Director of Government Affairs / Gilead

Amazing. I would recommend OVID to anyone. Clear, strategic, very informed advice and a pleasure to work with. OVID really did make it possible to run an impactful campaign and kept us on track, focused and without panic.

Athena Lamnisos
Chief Executive / The Eve Appeal